| Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey, F Richter, M Samara, ... The Lancet 382 (9896), 951-962, 2013 | 2994 | 2013 |
| What does the PANSS mean? S Leucht, JM Kane, W Kissling, J Hamann, E Etschel, RR Engel Schizophrenia research 79 (2-3), 231-238, 2005 | 1225 | 2005 |
| Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A … S Leucht, G Pitschel-Walz, D Abraham, W Kissling Schizophrenia research 35 (1), 51-68, 1999 | 1148 | 1999 |
| Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis S Leucht, M Tardy, K Komossa, S Heres, W Kissling, G Salanti, JM Davis The Lancet 379 (9831), 2063-2071, 2012 | 1109 | 2012 |
| The effect of family interventions on relapse and rehospitalization in schizophrenia—a meta-analysis G Pitschel-Walz, S Leucht, J Bäuml, W Kissling, RR Engel Schizophrenia bulletin 27 (1), 73-92, 2001 | 1058 | 2001 |
| Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis C Rummel-Kluge, K Komossa, S Schwarz, H Hunger, F Schmid, ... Schizophrenia research 123 (2-3), 225-233, 2010 | 870 | 2010 |
| Clinical implications of brief psychiatric rating scale scores S Leucht, JM Kane, W Kissling, J Hamann, EVA Etschel, R Engel The British Journal of Psychiatry 187 (4), 366-371, 2005 | 862 | 2005 |
| New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis S Leucht, K Wahlbeck, J Hamann, W Kissling The Lancet 361 (9369), 1581-1589, 2003 | 785 | 2003 |
| Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials S Leucht, TRE Barnes, W Kissling, RR Engel, C Correll, JM Kane American Journal of Psychiatry 160 (7), 1209-1222, 2003 | 718 | 2003 |
| How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials S Leucht, D Arbter, RR Engel, W Kissling, JM Davis Molecular psychiatry 14 (4), 429-447, 2009 | 654 | 2009 |
| Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation … S Heres, J Davis, K Maino, E Jetzinger, W Kissling, S Leucht American Journal of Psychiatry 163 (2), 185-194, 2006 | 607 | 2006 |
| Oral versus depot antipsychotic drugs for schizophrenia—a critical systematic review and meta-analysis of randomised long-term trials C Leucht, S Heres, JM Kane, W Kissling, JM Davis, S Leucht Schizophrenia research 127 (1-3), 83-92, 2011 | 552 | 2011 |
| Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses S Leucht, S Hierl, W Kissling, M Dold, JM Davis The British Journal of Psychiatry 200 (2), 97-106, 2012 | 532 | 2012 |
| Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses M Huhn, M Tardy, LM Spineli, W Kissling, H Foerstl, G Pitschel-Walz, ... JAMA psychiatry 71 (6), 706-715, 2014 | 452 | 2014 |
| Guidelines for depot antipsychotic treatment in schizophrenia JM Kane, E Aguglia, AC Altamura, JLA Gutierrez, N Brunello, ... European Neuropsychopharmacology 8 (1), 55-66, 1998 | 452 | 1998 |
| Amisulpride, an unusual “atypical” antipsychotic: a meta-analysis of randomized controlled trials S Leucht, G Pitschel-Walz, RR Engel, W Kissling American Journal of Psychiatry 159 (2), 180-190, 2002 | 417 | 2002 |
| Shared decision making in psychiatry J Hamann, S Leucht, W Kissling Acta Psychiatrica Scandinavica 107 (6), 403-409, 2003 | 410 | 2003 |
| Shared decision making for in‐patients with schizophrenia J Hamann, B Langer, V Winkler, R Busch, R Cohen, S Leucht, W Kissling Acta Psychiatrica Scandinavica 114 (4), 265-273, 2006 | 402 | 2006 |
| Risperidone versus other atypical antipsychotics for schizophrenia K Komossa, C Rummel‐Kluge, S Schwarz, F Schmid, H Hunger, ... Cochrane Database of Systematic Reviews, 2011 | 375* | 2011 |
| Linking the PANSS, BPRS, and CGI: clinical implications S Leucht, JM Kane, E Etschel, W Kissling, J Hamann, RR Engel Neuropsychopharmacology 31 (10), 2318-2325, 2006 | 361 | 2006 |
